[A method for preventing recurrent scarring of the tympatic cavity in surgical treatment of patients with suppurative otitis media].
A trial of a novel pathogenetic method to prevent recurrent scarring in surgical treatment of patients with adhesive otitis media was made. The test group consisted of 36 patients with adhesive otitis media in whom surgical treatment was combined with application of mithomycin C (0.2 mg/ml) to the wound area. 27 patients of the control group received conventional treatment. The efficacy of the surgical treatment was assessed by reduction of the osteopneumatic interval. The results show that postoperative hearing was more stable in the test group.
Kriukov
A I
AI
Akhmedov
Sh M
ShM
Fedorova-Patiakina
O K
OK
Petrovskaia
A N
AN
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002921:Cicatrix / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D016685:Mitomycin / Q000627:therapeutic use; D010035:Otitis Media, Suppurative / Q000150:complications* / Q000188:drug therapy / Q000601:surgery*; D013506:Otologic Surgical Procedures / Q000379:methods*; D011183:Postoperative Complications; D011300:Preoperative Care; D055502:Secondary Prevention; D014432:Tympanic Membrane
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin